Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Goff

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|June 12, 2016
Since surgery isn't getting any easier, why is reimbursement going down? An update from the SGO taskforce on coding and reimbursementShitanshu Uppal, Mark S Shahin, Jill A Rathbun, et al.
Journal of Gynecologic Oncology|June 23, 2016
Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancersJovana Y Martin, Renata R Urban, John B Liao, et al.
Gynecologic Oncology|October 4, 2016
SGO Health Policy and Socioeconomic Committee: Current and Future Efforts of the Coding and Reimbursement Taskforce and the Policy, Quality and Outcomes TaskforceBarbara A Goff, Mark S Shahin, Matthew A Powell, et al.
JAMA|June 10, 2004
Frequency of symptoms of ovarian cancer in women presenting to primary care clinicsBarbara A Goff, Lynn S Mandel, Cindy H Melancon, et al.
Journal of Minimally Invasive Gynecology|January 24, 2018
Robotic, Laparoscopic, or Open Hysterectomy: Surgical Outcomes by Approach in Endometrial CancerTiffany L Beck, Melissa A Schiff, Barbara A Goff, et al.
Gynecologic Oncology|April 13, 2011
Patterns of spread and recurrence of sex cord-stromal tumors of the ovaryMelissa M Thrall, Pamela Paley, Ellen Pizer, et al.
American Journal of Obstetrics and Gynecology|June 26, 2003
Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Oncology Consortium (PSOC 1602)Barbara A Goff, Tove Thompson, Benjamin E Greer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
Evaluation of a Validated Biomarker Test in Combination With a Symptom Index to Predict Ovarian MalignancyRenata R Urban, Alan Smith, Kathy Agnew, et al.
Integrative Cancer Therapies|April 30, 2013
Adverse events associated with complementary and alternative medicine use in ovarian cancer patientsErin S Sweet, Leanna J Standish, Barbara A Goff, et al.
Gynecologic Oncology|December 7, 2017
The end of life costs for Medicare patients with advanced ovarian cancerRenata R Urban, Hao He, Raphael Alfonso, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|June 12, 2016
Since surgery isn't getting any easier, why is reimbursement going down? An update from the SGO taskforce on coding and reimbursementShitanshu Uppal, Mark S Shahin, Jill A Rathbun, et al.
Journal of Gynecologic Oncology|June 23, 2016
Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancersJovana Y Martin, Renata R Urban, John B Liao, et al.
Gynecologic Oncology|October 4, 2016
SGO Health Policy and Socioeconomic Committee: Current and Future Efforts of the Coding and Reimbursement Taskforce and the Policy, Quality and Outcomes TaskforceBarbara A Goff, Mark S Shahin, Matthew A Powell, et al.
JAMA|June 10, 2004
Frequency of symptoms of ovarian cancer in women presenting to primary care clinicsBarbara A Goff, Lynn S Mandel, Cindy H Melancon, et al.
Journal of Minimally Invasive Gynecology|January 24, 2018
Robotic, Laparoscopic, or Open Hysterectomy: Surgical Outcomes by Approach in Endometrial CancerTiffany L Beck, Melissa A Schiff, Barbara A Goff, et al.
Gynecologic Oncology|April 13, 2011
Patterns of spread and recurrence of sex cord-stromal tumors of the ovaryMelissa M Thrall, Pamela Paley, Ellen Pizer, et al.
American Journal of Obstetrics and Gynecology|June 26, 2003
Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Oncology Consortium (PSOC 1602)Barbara A Goff, Tove Thompson, Benjamin E Greer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
Evaluation of a Validated Biomarker Test in Combination With a Symptom Index to Predict Ovarian MalignancyRenata R Urban, Alan Smith, Kathy Agnew, et al.
Integrative Cancer Therapies|April 30, 2013
Adverse events associated with complementary and alternative medicine use in ovarian cancer patientsErin S Sweet, Leanna J Standish, Barbara A Goff, et al.
Gynecologic Oncology|December 7, 2017
The end of life costs for Medicare patients with advanced ovarian cancerRenata R Urban, Hao He, Raphael Alfonso, et al.
Pageof 13